Real-world data on the efficacy and safety of adjuvant chemotherapy in Japanese patients with a high-risk of gastrointestinal stromal tumor recurrence.
Yuki UshimaruTsuyoshi TakahashiKiyokazu NakajimaRyugo TeranishiToshirou NishidaSeiichi HirotaMasaaki MotooriTakeshi OmoriRyohei KawabataKazuhiro NishikawaTakuro SaitoKotaro YamashitaKoji TanakaTomoki MakinoKazuyoshi YamamotoYukinori KurokawaHidetoshi EguchiYuichiro DokiPublished in: International journal of clinical oncology (2022)
Postoperative AC was well tolerated by Japanese patients at an acceptable rate, and its use may reduce the risk of recurrence in patients with high-risk GISTs.